Cargando…
Insider information: Testing cancer drug sensitivity for personalized therapy
Cancer death is usually caused by incurable drug-resistant and metastatic cancers. Although tremendous progress has been made in anticancer drug development during the past two decades, cancer medicine still faces unprecedented challenges associated with choosing effective treatments for individual...
Autores principales: | Wang, Jing, Wei, Qiang, Ye, Jixing, Denduluri, Sahitya K., Wang, Xin, Mohammed, Maryam K., Luu, Hue H., Haydon, Rex C., He, Tong-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610196/ https://www.ncbi.nlm.nih.gov/pubmed/26491709 http://dx.doi.org/10.1016/j.gendis.2015.05.004 |
Ejemplares similares
-
Molecular pathogenesis and therapeutic strategies of human osteosarcoma
por: Denduluri, Sahitya K, et al.
Publicado: (2016) -
Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance
por: Denduluri, Sahitya K., et al.
Publicado: (2014) -
TqPCR: A Touchdown qPCR Assay with Significantly Improved Detection Sensitivity and Amplification Efficiency of SYBR Green qPCR
por: Zhang, Qian, et al.
Publicado: (2015) -
Wnt versus Hippo: A balanced act or dynamic duo?
por: Wang, Zhongliang, et al.
Publicado: (2014) -
Sustained high level transgene expression in mammalian cells mediated by the optimized piggyBac transposon system
por: Chen, Xiang, et al.
Publicado: (2015)